Singleplex Immunoassay Market Research Report – Forecast to 2027

Singleplex Immunoassay Market Research Report: By Products and Services (Consumables, Others), by Type (Protein-Based Assays, Nucleic Acid Based Assays, Others), Technology (Flow Cytometry, Others), Application, End-User - Forecast Till 2027

ID: MRFR/LS/4737-HCR | November 2022 | Region: Global | 100 Pages         

Singleplex Immunoassay Market Scenario

The singleplex immunoassay market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global singleplex immunoassay market is expected to register a CAGR ~ 8.4 % during the forecast period of 2018–2023.

Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multiple intracellular and extracellular proteins. Moreover, singleplex immunoassay provides a fast and high-through output solution for gene expression quantification. For instance, Thermo Fisher Scientific’s QuantiGene Singleplex assay is developed to detect original RNA or DNA population using signal amplification.

Numerous factors such as growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, and rising use of immunoassay in oncology fuels the growth of global singleplex immunoassay. Additionally, that rising prevalence of chronic diseases will push the demand for singleplex immunoassay technologies.

Moreover, the growing awareness about immunoassay, enhanced focus on diagnostic testing, and increasing government assistance are continuously contributing to the growth of the global singleplex immunoassay market.

Despite the drivers, some factors such as the stringent FDA regulations, the emergence of multiplex immunoassays, the complex procedure of testing, and poor healthcare system in low and middle-income countries may hamper the growth of the market to an extent.

Company Profiles    

  • Luminex

  • Thermo Fisher Scientific

  • Illumina

  • Bio-Rad Laboratories


  • Abcam

  • Becton Dickinson and Company

  • Merck Life sciences

  • Agilent Technologies

  • Quanterix

  • Bio-Techne

  • Olink

  • Seegene

  • BioVendor

  • Others


The global singleplex immunoassay market is segmented on the basis of the product and service, type, technology, application, and end-user.

On the basis of the product and services, the market is classified as consumables, instruments, and others.

The global singleplex immunoassay market on the basis of the type is segmented as protein-based assays, nucleic acid-based assays, cell-based assays, and others.

On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, and others.

The singleplex immunoassay global market, by application, is segmented into research and development, clinical diagnostics, and others. The research and development are further segmented into drug discovery & development and biomarker discovery and validation. The clinical diagnostics are further segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and metabolism & endocrinology disorders.

On the basis of the end-user, the market is segmented as pharmaceutical & biotechnology companies, hospitals & research institutes, reference laboratories and others.

Geographically, the market has been segmented into America, Europe, Asia-Pacific, and the Middle East & Africa. The Americas singleplex immunoassay market is further segmented into North America, and South America. North America is further classified as the US and Canada.

The Europe market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UKUK, Italy, Spain, and the Rest of Western Europe.

The Asia-Pacific market is segmented into Japan, China, India, Republic of Korea, Australia, and Rest of Asia-Pacific.

The Middle East & Africa market is segmented into the Middle East, and Africa.

Regional Market Summary

Singleplex Immunoassay Global Market, by Region Market Share, 2017 (%)

 Singleplex Immunoassay Market

Source: MRFR Analysis

The global singleplex immunoassay market consists of four regions: Americas, Europe, Asia-Pacific and the Middle East & Africa. The Americas is expected to dominate the singleplex immunoassay market owing to the presence of major market players, high adoption rate, and increasing prevalence of infectious diseases. According to the statistics suggested by the Centers for Disease Control (CDC) and Prevention, in 2014,  around 9,421 cases of tuberculosis, 51,455 cases of salmonella, 33,461 cases of Lyme disease, and 433 cases of meningococcal disease were registered in the United States.

Europe is anticipated to hold the second position in the global singleplex immunoassay market. It is expected that the rising automation in an immunoassay, increasing prevalence of chronic diseases, funding provided by the government, and private organizations towards research & development are anticipated to drive the European market.

The Asia-Pacific singleplex immunoassay market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is the fastest growing in singleplex immunoassay market. Major factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in the biotechnology sector, increasing healthcare expenditure influences the market in this region. Additionally, according to the data suggested by the Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was USD 170.4 billion, i.e., 3.6 % higher than the expenditure of 2014-2015.

The Middle East and Africa hold the least share in the global singleplex immunoassay market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth.

Research Methodology

Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.

  • Primary Research

The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

  • Secondary Research

Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global singleplex immunoassay market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.

Global Singleplex Immunoassay Market, by Product and Service

  • Consumables

  • Instruments

  • Others

Global Singleplex Immunoassay Market, by Type

  • Protein-Based Assays

  • Nucleic Acid Based Assays

  • Cell-Based Assays

  • Others

Global Singleplex Immunoassay Market, by Technology

  • Flow Cytometry

  • Fluorescence Detection

Global Singleplex Immunoassay Market, by Application

  • Research & Development

  • Drug Discovery & Development

  • Biomarker Discovery & Validation

  • Clinical Diagnostics

  • Infectious Diseases

  • Cancer

  • Cardiovascular Diseases

  • Autoimmune Diseases

  • Nervous System Disorders

  • Metabolism & Endocrinology Disorders

  • Others

Global Singleplex Immunoassay Market, by End-user

  • Pharmaceutical & Biotechnology Companies

  • Hospitals & Research Institutes

  • Reference Laboratories

  • Others

Global Singleplex Immunoassay Market, by Region

  • North America

    • US

    • Canada

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • Latin America

Intended Audience

  • Pharmaceutical Companies

  • Medical Device Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities

Report Scope:

Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   2018-2023: ~8.4%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product And Service, Type, Technology, Application, And End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, QIAGEN N.V, Abcam, Becton Dickinson and Company, Merck Life sciences, Agilent Technologies, Quanterix, Bio-Techne, Olink, Seegene, BioVendor
  Key Market Opportunities   Government assistance
  Key Market Drivers   Rising prevalence of chronic diseases and growing biotechnology sector

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Singleplex Immunoassay Market is projected to grow at an 8.4% CAGR between 2018-2023.

The Americas is expected to lead the Singleplex Immunoassay Market.

Rising prevalence of chronic diseases and growing biotechnology sector is boosting market growth.

Poor healthcare system may limit market growth.

Different strategies used by market players to create a dominance in the Singleplex Immunoassay Market growth include mergers, collaborations, product developments, and R&D.